OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
Lasse Kjær
Cancers (2020) Vol. 12, Iss. 8, pp. 2100-2100
Open Access | Times Cited: 23

Showing 23 citing articles:

Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
Mihnea‐Alexandru Găman, Vincent Kipkorir, Bahadar S. Srichawla, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 388-388
Open Access | Times Cited: 10

Production and Characterization of Peptide Antibodies to the C-Terminal of Frameshifted Calreticulin Associated with Myeloproliferative Diseases
Farah Perveen Mughal, Ann Christina Bergmann, Ha Uyen Buu Huynh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6803-6803
Open Access | Times Cited: 15

Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis
Giovanna Carrà, Emilia Giugliano, Sofia Camerlo, et al.
Haematologica (2022) Vol. 108, Iss. 5, pp. 1447-1449
Open Access | Times Cited: 15

Quantitative interpretation of bone marrow biopsies in MPN—What's the point in a molecular age?
Hosuk Ryou, Oliver Lomas, Helen Theissen, et al.
British Journal of Haematology (2023) Vol. 203, Iss. 4, pp. 523-535
Open Access | Times Cited: 8

The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
Marco Pizzi, Giorgio Alberto Croci, Marco Ruggeri, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5666-5666
Open Access | Times Cited: 20

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
Hans Carl Hasselbalch, Peter Junker, Vibe Skov, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4323-4323
Open Access | Times Cited: 5

Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies
Baixin Ye, Yuping Sheng, Mingming Zhang, et al.
Cancer Letters (2022) Vol. 538, pp. 215691-215691
Closed Access | Times Cited: 8

The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms
Thibaut d’Izarny-Gargas, Pierre Isnard, Idris Boudhabhay, et al.
Kidney International (2023) Vol. 104, Iss. 6, pp. 1206-1218
Open Access | Times Cited: 4

Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms
Tobias Idor Boklund, Jordan Snyder, Johanne Gudmand‐Hoeyer, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War eras
Andrew Tiu, Zoe McKinnell, Shanshan Liu, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 10, pp. 1969-1978
Open Access | Times Cited: 1

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease
Yi‐Chun Huang, Chao‐Yung Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9867-9867
Open Access | Times Cited: 9

Whole Exome Sequencing Reveals Novel Variants in Unexplained Erythrocytosis
Harshit Khurana, Babylakshmi Muthusamy, Uday Yanamandra, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 7, pp. 299-304
Open Access | Times Cited: 2

Calreticulin gene mutation in BCR-ABL1 negative myeloproliferative neoplasms: relation to clinical, laboratory and morphological findings
Olfat Hendy, Hoda Mohamed El Gendi, Nesma Ahmed Safwat, et al.
The Egyptian Journal of Haematology (2024) Vol. 49, Iss. 3, pp. 244-254
Closed Access

Molecular diagnostic criteria of myeloproliferative neoplasms
Claire Andrews, Eibhlin Conneally, Stephen E. Langabeer
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 12, pp. 1077-1090
Closed Access | Times Cited: 1

Dose‐dependent mathematical modeling of interferon‐α‐treatment for personalized treatment of myeloproliferative neoplasms
Rasmus Kristoffer Pedersen, Morten Andersen, Trine Alma Knudsen, et al.
Computational and Systems Oncology (2021) Vol. 1, Iss. 4
Open Access | Times Cited: 3

Clonal hematopoiesis in idiopathic cytopenia of undetermined significance
Hanyang Wu, Chao‐yang Gu, Shuang Liu, et al.
Research Square (Research Square) (2023)
Open Access

Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms
Margherita Vieri, Vithurithra Tharmapalan, Milena Kalmer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Molecular Landscape and Personalized Prognostic Prediction of MPNs
Harinder Gill, Yammy Yung, Cherry Chu, et al.
(2023), pp. 501-513
Closed Access

Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
Linet Njue, Naomi Porret, Ulrike Bacher, et al.
healthbook TIMES Oncology Hematology (2020), Iss. 6
Open Access

Page 1

Scroll to top